RU2014114121A - MEANS AND METHOD FOR LOCAL TREATMENT OF PAPULO-EMPTY ROZACEA - Google Patents
MEANS AND METHOD FOR LOCAL TREATMENT OF PAPULO-EMPTY ROZACEA Download PDFInfo
- Publication number
- RU2014114121A RU2014114121A RU2014114121/15A RU2014114121A RU2014114121A RU 2014114121 A RU2014114121 A RU 2014114121A RU 2014114121/15 A RU2014114121/15 A RU 2014114121/15A RU 2014114121 A RU2014114121 A RU 2014114121A RU 2014114121 A RU2014114121 A RU 2014114121A
- Authority
- RU
- Russia
- Prior art keywords
- morning
- day
- evening
- days
- local
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Применение средства Сетаф® Dermacontrol ил ™ для местного лечения папуло-пустулезной формы розацеа.2. Способ местного лечения папуло-пустулезной формы розацеа, заключающийся в проведении дезинтоксикационная терапии, включающей антигистаминные и седативные препараты в сочетании с местной фармакотерапией, отличающийся тем, что местную терапию проводят по следующей схеме: на чистое лицо на пораженные участки наносят 5% серную мазь 2 раза в день утром и вечером в течение 3 дней, затем 10% серную мазь 2 раза в день утром и вечером в течение 3 дней, после чего 20% серную мазь 10 дней по 2 раза в день утром и вечером, затем наносят гель Азелик 15% 2 раза в день на сухое чистое лицо утром и вечером в течение 3-4 месяцев, далее, продолжают по 1 разу в день утром в течение 3-4 месяцев, на протяжении всего курса лечения для умывания утром и вечером используют средство Сетафил® Dermacontrol™ и увлажняющее средство для лица SPF30 по 1 разу в день утром после умывания пенкой или через 40-60 минут после нанесения лекарственного препарата.1. The use of Setaf® Dermacontrol il ™ for topical treatment of the papulopustular form of rosacea. 2. A method of local treatment of the papulopustular form of rosacea, which consists of detoxification therapy, including antihistamines and sedatives in combination with local pharmacotherapy, characterized in that the local therapy is carried out according to the following scheme: 5% sulfuric ointment is applied to the affected areas 2 times a day in the morning and evening for 3 days, then 10% sulfuric ointment 2 times a day in the morning and evening for 3 days, after which 20% sulfuric ointment 10 days 2 times a day in the morning and evening, then apply Azelik gel 15% 2 times a day l on a dry, clean face in the morning and evening for 3-4 months, then continue once a day in the morning for 3-4 months, throughout the course of treatment, Setafil® Dermacontrol ™ and a moisturizer are used for washing in the morning and evening for face SPF30 once a day in the morning after washing with foam or 40-60 minutes after applying the drug.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014114121/15A RU2583559C2 (en) | 2014-04-09 | 2014-04-09 | Device and method for local treatment of papulo-papulopustular shape rosacea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014114121/15A RU2583559C2 (en) | 2014-04-09 | 2014-04-09 | Device and method for local treatment of papulo-papulopustular shape rosacea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014114121A true RU2014114121A (en) | 2015-10-27 |
| RU2583559C2 RU2583559C2 (en) | 2016-05-10 |
Family
ID=54362535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014114121/15A RU2583559C2 (en) | 2014-04-09 | 2014-04-09 | Device and method for local treatment of papulo-papulopustular shape rosacea |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2583559C2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2645932C1 (en) * | 2017-02-15 | 2018-02-28 | Ольга Юрьевна Олисова | Method of complex extrinsic for patients with erithematous papular rosacea |
| RU2741988C1 (en) * | 2020-08-05 | 2021-02-01 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Амурская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method of antioxidant status correction in treating erythematous-telangiectatic and papulopustular forms of rosacea of mild and moderate severity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060128808A1 (en) * | 2004-10-20 | 2006-06-15 | Galderma Research & Development, S.N.C. | Method of using adapalene in acne maintenance therapy |
| US8853275B2 (en) * | 2008-05-16 | 2014-10-07 | Galderma Research & Development | Concurrent therapy regime/regimen for the treatment of acne related diseases |
-
2014
- 2014-04-09 RU RU2014114121/15A patent/RU2583559C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2583559C2 (en) | 2016-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790195A1 (en) | METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS | |
| MY199033A (en) | Keratin treatment formulations and methods | |
| BR112014018471A2 (en) | anti-ige m1 'antibodies and methods of use | |
| MX2017013983A (en) | Use of active agents during chemical treatments. | |
| EA201490746A2 (en) | APPLICATION OF PROGESTERON IN PREVENTION AND AFTER A ACUTE PERIOD TO IMPROVE THE OUTCOMES ASSOCIATED WITH THE CONVERGENCE OF THE BRAIN | |
| EA201692334A1 (en) | CORTICOSTEROID COMPOSITIONS FOR LOCAL APPLICATION | |
| ECSP22038978A (en) | INHIBITION OF HUMAN INTEGRIN ALPHA4ß7 | |
| BR112016000335A8 (en) | method of treatment of papulopustular rosacea, treatment of inflammatory lesions of papulopustular rosacea and use of a pharmaceutical composition | |
| EA201591413A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SURFACE RAS | |
| BR112015033053A2 (en) | cancer treatment method in a subject, method of stimulating the immune system in a subject, method of increasing the distribution of an anticancer agent to a tumor cell, composition, and kit | |
| WO2019040106A3 (en) | Compounds, salts thereof and their use in the treatment of diseases | |
| CO7141430A2 (en) | Vesicular formulations for use in the treatment of pain or reduced mobility of a joint | |
| BR112016015997A2 (en) | ? PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND 15- HEPE AND METHODS TO TREAT ASTHMA AND PULMONARY DISORDERS WITH THE USE OF THEM? | |
| CL2013002551A1 (en) | Antibody molecule against dabigatran; manufacturing method; and its use to treat or prevent the side effects of anticoagulant therapy or an overdose event in anticoagulant therapy. | |
| BR112016029996A2 (en) | cosmetic use, composition and cosmetic method to treat body odors | |
| BR112018014762A2 (en) | method of treating (early) alzheimer's disease | |
| AR095594A1 (en) | METHODS TO TREAT INFECTIONS IN PATIENTS WITH OVERWEIGHT AND OBESOS USING ANTIBIOTICS | |
| RU2014114121A (en) | MEANS AND METHOD FOR LOCAL TREATMENT OF PAPULO-EMPTY ROZACEA | |
| EA202090260A1 (en) | MEANS AND METHODS FOR HUMAN AAV GENOTHERAPY | |
| WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
| BR112015022025A8 (en) | composition and use of an active agent | |
| MX2017006657A (en) | Method for the prevention and treatment of acne. | |
| WO2019126695A3 (en) | Methods and pharmaceutical compositions for treating candida auris in blood | |
| RU2014125665A (en) | METHOD FOR EXTERNAL TREATMENT OF SKIN MYKOSIS | |
| UA115417U (en) | METHOD OF PREVENTION AND TREATMENT OF HYPOXIC CHANGES IN CARBOPERITONEUM |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20160529 |